FDA Approved: AMBRISENTAN — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex Corp.'s original application for ambrisentan, a generic form of the pulmonary arterial hypertension treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ambrisentan (Ambrisentan)

Snippet

ORIG AP for AMBRISENTAN (AMBRISENTAN)